NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Nippon India Mutual Fund Acquires Additional Stake in ICRA

On April 7, Nippon India Mutual Fund made a significant move by acquiring an additional 1.5 percent equity stake worth more than Rs 73 crore in rating agency ICRA through open market transactions.

ICRA shares closed the day with a gain of 0.16 percent at Rs 5,115.5, with the highest volumes traded since July 3, 2025. The stock has experienced consolidation over the last five-six sessions. Nippon India Mutual Fund acquired 1.44 lakh shares (1.5 percent stake) for Rs 73.56 crore through two transactions, with a buying price of Rs 5,075 per share.

Nippon Life India Trustee, through its Nippon India Small Cap Fund, already held a 6.88 percent stake in ICRA as of March 2026.

Read also: Market Analysis: Key Stocks to Watch - Narayana Hrudayalaya, ABB India, Federal Bank, Premier Energies, Ather Energy and More

EntityStakeValue (Crore)
Nippon India Mutual Fund1.5%73.56
Nippon Life India Trustee (Nippon India Small Cap Fund)6.88%-
Goldman Sachs Funds (Goldman Sachs India Equity Portfolio)0.62%-
Eastspring Investments India Equity Open0.73%-
Bhaskara Rao Bollineni2.9%-

Meanwhile, Cello World, a houseware company, saw its shares rise 0.21 percent to Rs 402.65 on the National Stock Exchange. Goldman Sachs Funds, through its Goldman Sachs India Equity Portfolio, sold 13.82 lakh shares (0.62 percent stake) in Cello World at Rs 401 per share, valued at Rs 55.45 crore.

EntityStakeValue (Crore)
Goldman Sachs Funds (Goldman Sachs India Equity Portfolio)0.62%55.45
Eastspring Investments India Equity Open1.14%-
Bhaskara Rao Bollineni2.9%-

Mahanagar Gas, the natural gas distribution company, also saw significant activity. Eastspring Investments India Equity Open, a part of Prudential plc's Eastspring Investments, offloaded 7.25 lakh shares (0.73 percent stake) for Rs 69.39 crore, with a selling price of Rs 957.01 per share.

Read also: FirstClub Secures $55 Million in Funding from Peak XV, Sofina, and Other Investors 9 Months After $22 Million Series A Round

EntityStakeValue (Crore)
Eastspring Investments India Equity Open0.73%69.39
Bhaskara Rao Bollineni2.9%-

In another notable transaction, non-institutional investor Bhaskara Rao Bollineni acquired an additional 5.12 lakh shares (1.15 percent stake) in Sai Parenterals, the pharmaceuticals company, at Rs 409.25 per share, valued at Rs 20.96 crore. Bhaskara Rao already held a 2.9 percent stake in the company as of March 2026. The stock may have reacted to this deal, rising 0.64 percent to Rs 409.25.

Finally, in GSP Crop Science, PSL bought 2.5 lakh shares at Rs 388.29 per share, while Longthrive Capital VCC through Gamma View Funds sold the same number of shares at Rs 388.25 per share, valued at Rs 9.7 crore.

Investor Takeaway

Nippon India Mutual Fund has increased its stake in ICRA, while Goldman Sachs has offloaded shares in Cello World.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.